Allogeneic MHC class I ligands and their role in positive and negative regulation of human cytotoxic effector cells

Human Immunology

Volumn 63, Issue 1, 2002, Pages 8-19

  Falk, Christine S ^a   Schendel, Dolores J ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; AMINO ACID; CD3 ANTIGEN; CD48 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CD94 ANTIGEN; CYTOKINE; HLA A2 ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; IMMUNOGLOBULIN; LECTIN; LECTIN RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; PHOSPHATASE; RECEPTOR; T LYMPHOCYTE RECEPTOR;

ARTICLE; CYTOTOXIC T LYMPHOCYTE; EFFECTOR CELL; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; LIGANDS; LYMPHOCYTE CULTURE TEST, MIXED; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, IMMUNOLOGIC; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0036143408     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(01)00360-3     Document Type: Article

References (89)

1. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor
2. Expression of HLA class I-specific inhibitory natural killer cell receptors in HIV-specific cytolytic T lymphocytes: Impairment of specific cytolytic functions
3. HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes: Molecular characterization, distribution in lymphoid tissues and co-expression by individual T cells
4. Non-MHC-restricted CD4+ T lymphocytes are regulated by HLA-Cw7-mediated inhibition
5. Expression of HLA-C molecules confers target cell resistance to some non-major histocompatibility complex-restricted T cells in a manner analogous to allospecific natural killer cells
6. Role of peptides in allorecognition
7. Expression of HLA class I-specific inhibitory receptors in human cytolytic T lymphocytes: A regulated mechanism that controls T-cell activation and function
8. Cytokine-induced expression of killer inhibitory receptors in human T lymphocytes
9. Regulation of KIR expression in human T cells: A safety mechanism that may impair protective T-cell responses
10. HLA class I recognition by killer cell Ig-like receptors
11. Face off - The interplay between activating and inhibitory immune receptors
12. On guard - Activating NK cell receptors
13. Immune inhibitory receptors
14. The origin and functions of natural killer cells
15. The TAP complex influences allorecognition of class II MHC molecules
16. Structural aspects of allorecognition
17. The specificity of alloreactive T cells is determined by MHC polymorphisms which contact the T cell receptor and which influence peptide binding
18. The molecular basis of allorecognition of major histocompatibility complex molecules by T lymphocytes
19. The molecular basis of alloreactivity
20. The HLA likes and dislikes of allospecific and non-MHC-restricted cytotoxic T lymphocytes
21. The molecular basis of allorecognition
22. Alloreactive T cells discriminate among a diverse set of endogenous peptides
23. Role of endogenous peptide in human alloreactive cytotoxic T cell responses
24. TAP-independent MHC class I peptide antigen presentation to alloreactive CTL is enhanced by target cell incubation at subphysiologic temperatures
25. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes
26. Early signaling via inhibitory and activating NK receptors
27. Immunoreceptor tyrosine-based inhibirion motifs
28. A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation
29. Inhibitory and activatory receptors for MHC class I molecules
30. Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells
31. Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules
32. Molecular analyses of the interactions between human NK receptors and their HLA ligands
33. HLA class I specific inhibitory receptors
34. Natural killer cell receptors and MHC class I interactions
35. Regulation of immune responses through inhibitory receptors
36. A novel family of Ig-like receptors for HLA class I molecules that modulate function of lymphoid and myeloid cells
37. A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells
38. LIRs/ILTs/MIRs, inhibitory and stimulatory Ig-superfamily receptors expressed in myeloid and lymphoid cells
39. A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules
40. Paired inhibitory and triggering NK cell receptors for HLA class I molecules
41. NK cell recognition of non-classical HLA class I molecules
42. NK cell activation: Distinct stimulatory pathways counterbalancing inhibitory signals
43. The ITAM-bearing transmembrane adaptor DAP12 in lymphoid and myeloid cell function
44. A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B*2705
45. Signaling pathways engaged by NK cell receptors: Double concerto for activating receptors, inhibitory receptors and NK cells
46. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
47. TAP-and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide
48. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis
49. Human natural killer cell activating receptors
50. Human NK-cell receptors
51. Identification of NKp80, a novel triggering molecule expressed by human NK cells
52. Turning on natural killer cells
53. Multifaceted roles of MHC class I and MHC class I-like molecules in T cell activation
54. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor
55. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA
56. An activating immunoreceptor complex formed by NKG2D and DAP10
57. Role of NKG2D in tumor cell lysis mediated by human NK cells: Cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin
58. Mica engagement by human vgamma2vdelta2 t cells enhances their antigen-dependent effector function
59. Costimulation of CD8alphabeta T cells by NKG2D via engagement by MIC induced on virus-infected cells
60. The CD2-subset of the Ig superfamily of cell surface molecules: Receptor-ligand pairs expressed by NK cells and other immune cells
61. 2B4: An NK cell activating receptor with unique specificity and signal transduction mechanism
62. Distinct interactions of the x-linked lymphoproliferative syndrome gene product sap with cytoplasmic domains of members of the cd2 receptor family
63. Potential pathways for regulation of NK and T cell responses: Differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4
64. Involvement of inhibitory NKRs in the survival of a subset of memory-phenotype CD8+ T cells
65. The repertoire of killer cell Ig-like receptor and CD94:NKG2A receptors in T cells: Clones sharing identical alpha beta TCR rearrangement express highly diverse killer cell Ig-like receptor patterns
66. Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL
67. C-type lectin-like receptors in peptide-specific HLA class I-restricted cytotoxic T lymphocytes: Differential expression and modulation of effector functions in clones sharing identical TCR structure and epitope specificity
68. HLA-class I-specific inhibitory receptors in HIV-1 infection
69. Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas
70. Analysis of immune reconstitution in children undergoing cord blood transplantation
71. Does the emergence and persistence of donor-derived leukaemia-reactive cytotoxic T lymphocytes protect patients given an allogeneic BMT from recurrence? Results of a preliminary study
72. HLA class I-specific inhibitory receptors in human T lymphocytes: Interleukin 15-induced expression of CD94/NKG2A in superant
73. Noncanonical Valpha24JalphaQ T cells with conservative alpha chain CDR3 region amino acid substitutions are restricted by CD1d
74. NKT cells: Facts, functions and fallacies
75. Recognition and function of Valphal4 NKT cells
76. Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A, -B, -C null human cell line
77. Nomenclature for factors of the HLA system, 1995
78. Identification of seventeen novel KIR variants: Fourteen of them from two non-Caucasian donors
79. Allo-major histocompatibility complex-restricted cytotoxic T lymphocytes engraft in bone marrow transplant recipients without causing graft-versus-host disease
80. Immunotherapy with CTLs restricted by nonself MHC
81. Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1
82. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. Japan marrow donor program
83. The HLA crossroad in tumor immunology
84. HLA and cancer: From research to clinical impact
85. Gene transfer of human interferon gamma complementary DNA into a renal cell carcinoma line enhances MHC-restricted cytotoxic T lymphocyte recognition but suppresses non-MHC-restricted effector cell activity
86. Viral mechanisms of immune evasion
87. Can viruses help us to understand and classify the MHC class I molecules at the maternal-fetal interface?
88. Standardization of the human in vitro cell-mediated lympholysis technique
89. Retaliation against tumor cells showing aberrant HLA expression using lymphokine activated killer (LAK)-derived T cells